BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25001623)

  • 1. ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis.
    Heo KS; Cushman HJ; Akaike M; Woo CH; Wang X; Qiu X; Fujiwara K; Abe J
    Circulation; 2014 Jul; 130(2):180-91. PubMed ID: 25001623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulinastatin promotes macrophage efferocytosis and ameliorates lung inflammation via the ERK5/Mer signaling pathway.
    Li J; Shao R; Xie Q; Qin K; Ming S; Xie Y; Du X
    FEBS Open Bio; 2022 Aug; 12(8):1498-1508. PubMed ID: 35778889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.
    Doran AC; Ozcan L; Cai B; Zheng Z; Fredman G; Rymond CC; Dorweiler B; Sluimer JC; Hsieh J; Kuriakose G; Tall AR; Tabas I
    J Clin Invest; 2017 Nov; 127(11):4075-4089. PubMed ID: 28972541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis.
    Doddapattar P; Dev R; Ghatge M; Patel RB; Jain M; Dhanesha N; Lentz SR; Chauhan AK
    Circ Res; 2022 Apr; 130(9):1289-1305. PubMed ID: 35400205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet.
    Li S; Sun Y; Liang CP; Thorp EB; Han S; Jehle AW; Saraswathi V; Pridgen B; Kanter JE; Li R; Welch CL; Hasty AH; Bornfeldt KE; Breslow JL; Tabas I; Tall AR
    Circ Res; 2009 Nov; 105(11):1072-82. PubMed ID: 19834009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
    Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation.
    Yancey PG; Blakemore J; Ding L; Fan D; Overton CD; Zhang Y; Linton MF; Fazio S
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):787-95. PubMed ID: 20150557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2
    Wang W; Liu W; Fidler T; Wang Y; Tang Y; Woods B; Welch C; Cai B; Silvestre-Roig C; Ai D; Yang YG; Hidalgo A; Soehnlein O; Tabas I; Levine RL; Tall AR; Wang N
    Circ Res; 2018 Nov; 123(11):e35-e47. PubMed ID: 30571460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective activation of CB2 receptor improves efferocytosis in cultured macrophages.
    Jiang L; Chen Y; Huang X; Yuan A; Shao Q; Pu J; He B
    Life Sci; 2016 Sep; 161():10-8. PubMed ID: 27474129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis.
    Tao H; Yancey PG; Babaev VR; Blakemore JL; Zhang Y; Ding L; Fazio S; Linton MF
    J Lipid Res; 2015 Aug; 56(8):1449-60. PubMed ID: 26059978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoproteasome subunit β5i regulates diet-induced atherosclerosis through altering MERTK-mediated efferocytosis in Apoe knockout mice.
    Liao J; Xie Y; Lin Q; Yang X; An X; Xia Y; Du J; Wang F; Li HH
    J Pathol; 2020 Mar; 250(3):275-287. PubMed ID: 31758542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis.
    Seneviratne AN; Edsfeldt A; Cole JE; Kassiteridi C; Swart M; Park I; Green P; Khoyratty T; Saliba D; Goddard ME; Sansom SN; Goncalves I; Krams R; Udalova IA; Monaco C
    Circulation; 2017 Sep; 136(12):1140-1154. PubMed ID: 28698173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
    Thorp E; Tabas I
    J Leukoc Biol; 2009 Nov; 86(5):1089-95. PubMed ID: 19414539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.
    Yu P; Qian AS; Chathely KM; Trigatti BL
    Atherosclerosis; 2018 Sep; 276():171-181. PubMed ID: 29853191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonodynamic Therapy Promotes Efferocytosis via CD47 Down-Regulation in Advanced Atherosclerotic Plaque.
    Cao Y; Yao J; Gao W; Cao Z; Diabakte K; Wang L; Sun X; Tian Y
    Int Heart J; 2022 Jan; 63(1):131-140. PubMed ID: 35034916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis.
    Heo KS; Chang E; Le NT; Cushman H; Yeh ET; Fujiwara K; Abe J
    Circ Res; 2013 Mar; 112(6):911-23. PubMed ID: 23381569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.
    Kojima Y; Downing K; Kundu R; Miller C; Dewey F; Lancero H; Raaz U; Perisic L; Hedin U; Schadt E; Maegdefessel L; Quertermous T; Leeper NJ
    J Clin Invest; 2014 Mar; 124(3):1083-97. PubMed ID: 24531546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic cell death and efferocytosis in atherosclerosis.
    Van Vré EA; Ait-Oufella H; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):887-93. PubMed ID: 22328779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development.
    Zhang J; Zhao X; Guo Y; Liu Z; Wei S; Yuan Q; Shang H; Sang W; Cui S; Xu T; Yang K; Guo J; Pan C; Wang J; Pang J; Han T; Chen Y; Xu F
    Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):700-716. PubMed ID: 35354308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.